ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 373 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,072 | -0.8% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $284,382 | +125178.4% | 4,200 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $227 | -9.6% | 4,200 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $251 | -99.9% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $235,000 | -24.9% | 4,200 | -4.5% | 0.01% | 0.0% |
| Q1 2022 | $313,000 | -4.0% | 4,400 | -12.0% | 0.01% | 0.0% |
| Q4 2021 | $326,000 | -18.1% | 5,000 | -5.7% | 0.01% | -30.0% |
| Q3 2021 | $398,000 | -3.9% | 5,300 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $414,000 | -4.6% | 5,300 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $434,000 | -12.5% | 5,300 | -11.7% | 0.01% | -14.3% |
| Q4 2020 | $496,000 | +27.2% | 6,000 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $390,000 | -3.2% | 6,000 | -7.7% | 0.01% | -13.3% |
| Q2 2020 | $403,000 | -3.1% | 6,500 | 0.0% | 0.02% | -21.1% |
| Q1 2020 | $416,000 | – | 6,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |